BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8023555)

  • 21. Characterization of an immunoprotective protein complex of Anaplasma marginale by cloning and expression of the gene coding for polypeptide Am105L.
    Barbet AF; Palmer GH; Myler PJ; McGuire TC
    Infect Immun; 1987 Oct; 55(10):2428-35. PubMed ID: 2443451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteins containing an uncleaved signal for glycophosphatidylinositol membrane anchor attachment are retained in a post-ER compartment.
    Moran P; Caras IW
    J Cell Biol; 1992 Nov; 119(4):763-72. PubMed ID: 1385443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of vaccinia promoters by heterologous expression of hepatitis B surface antigen in mouse cells infected by recombinant vaccinia viruses.
    Barbeyron T; Mars M; Schroeder E; Malpièce Y; Plucienniczak A; Beaud G; Streeck RE
    Biochim Biophys Acta; 1987 Dec; 910(3):240-4. PubMed ID: 3676323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of enzyme-linked immunosorbent assays based on recombinant MSP1a and MSP2 of Anaplasma marginale.
    Araújo FR; Melo VS; Ramos CA; Madruga CR; Soares CO; Kessler RH; Almeida NF; Araújo GS; Alves LC; Torres Júnior RA; Fragoso SP; Arauco PR; Bacanelli G; Oliveira MB; Santos LR
    Mem Inst Oswaldo Cruz; 2005 Nov; 100(7):765-9. PubMed ID: 16410967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus.
    Yang S; Carroll MW; Torres-Duarte AP; Moss B; Davidson EA
    Vaccine; 1997; 15(12-13):1303-13. PubMed ID: 9302735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a competitive inhibition ELISA and the card agglutination test for detection of antibodies to Anaplasma marginale and Anaplasma centrale in cattle.
    Molloy JB; Bowles PM; Knowles DP; McElwain TF; Bock RE; Kingston TG; Blight GW; Dalgliesh RJ
    Aust Vet J; 1999 Apr; 77(4):245-9. PubMed ID: 10330556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic and molecular characterization of Anaplasma species infection in farm animals and ticks from Sicily.
    de la Fuente J; Torina A; Caracappa S; Tumino G; Furlá R; Almazán C; Kocan KM
    Vet Parasitol; 2005 Nov; 133(4):357-62. PubMed ID: 16043300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution and function of tandem repeats in the major surface protein 1a of the ehrlichial pathogen Anaplasma marginale.
    de La Fuente J; Garcia-Garcia JC; Blouin EF; Rodríguez SD; García MA; Kocan KM
    Anim Health Res Rev; 2001 Dec; 2(2):163-73. PubMed ID: 11831437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reintroduction of gene(s) into an attenuated deletion mutant of vaccinia virus strain IHD-W.
    Chang PY; Pogo BG
    Microb Pathog; 1993 Nov; 15(5):347-57. PubMed ID: 8015416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
    Zhang H
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):374-82. PubMed ID: 14599943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope-specific antibody and suppression of autoantibody responses against a hybrid self protein.
    Lohnas GL; Roberts SF; Pilon A; Tramontano A
    J Immunol; 1998 Dec; 161(12):6518-25. PubMed ID: 9862676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.
    Norimine J; Han S; Brown WC
    Immunogenetics; 2006 Sep; 58(9):726-39. PubMed ID: 16924490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE; Rodríguez D; Rodríguez JR; Abaitua F; Duarte C; Esteban M
    Vaccine; 2001 Dec; 20(5-6):961-71. PubMed ID: 11738764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nonfunctional sequence converted to a signal for glycophosphatidylinositol membrane anchor attachment.
    Moran P; Caras IW
    J Cell Biol; 1991 Oct; 115(2):329-36. PubMed ID: 1717483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of the myristylation signal allows high-level production of the hepatitis B virus large surface glycoprotein preS1 with vaccinia virus recombinants.
    Pfleiderer M; Falkner FG; Dorner F
    Gene; 1996 Oct; 176(1-2):131-7. PubMed ID: 8918244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.
    Himly M; Pfleiderer M; Holzer G; Fischer U; Hannak E; Falkner FG; Dorner F
    Protein Expr Purif; 1998 Dec; 14(3):317-26. PubMed ID: 9882565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification on the immunogenic activity of recombinant rLTB/CTB-LipL41/ 1 to Leptospira interrogans and detection of lipL41 gene with its production].
    Ruan P; Yan J; Mao YF; Peng HQ; Zhou XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Aug; 26(8):608-12. PubMed ID: 16390012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.